“…Screening studies show a high prevalence of CD (between 1/130-1/300) among both healthy children and adult populations in European countries (10,31) . In a recent study, the prevalence of CD in 2000 healthy blood donors was found to be 1.3% (1/166-1/104) in Iran (2,42) . Considering the wide range of clinical characteristics of CD, like anemia, osteoporosis, dermatitis herpetiformis, and neurologic problems and critical problems like non-Hodgkin's lymphoma, small bowel adenocarcinoma, esophageal cancer, and melanoma, early analysis of CD is crucial, because it is otherwise related to increased mortality (26,40,43) .…”